Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options



Rating:

Share or cite this content

Citations should be made in the following way:
K. Johannson (Calgary (AB), Canada). Treatment of interstitial lung diseases: current approaches and future directions. Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options

Member's Comments

No comment yet.

Related content which might interest you: Multidisciplinary evaluation of interstitial lung diseases: current insights Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017 Year: 2017 Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence Source: Eur Respir Rev, 27 (150) 180074; 10.1183/16000617.0074-2018 Year: 2018 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019 Year: 2020 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018 Year: 2018 The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective Source: International Congress 2019 – Rare lung diseases Year: 2019 Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010 Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions Source: Eur Respir Rev, 27 (147) 170076; 10.1183/16000617.0076-2017 Year: 2018 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 PET/CT in nononcological lung diseases: current applications and future perspectives Source: Eur Respir Rev 2016; 25: 247-258 Year: 2016 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Current challenges in diagnosing and treating adults with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Current developments and future directions in COPD Source: Eur Respir Rev, 29 (158) 200289; 10.1183/16000617.0289-2020 Year: 2020